Granted Patent
B2
US 7,652,149 · App. 11/095,381 · Granted Jan 26, 2010
Crystalline pyrazoles
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to crystal forms of 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide and methods for preparation, interconversion, and isolation of such crystals.
Claims (1)
1. A crystal form, Form I, of 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide having a powder X-ray diffraction pattern comprising peaks expressed in degrees (±0.1 degree) of two theta angle of 14.0, 18.9, 21.3, 21.9, and 25.7 obtained using CuKα 1 X-ray (wavelength=1.5406 Angstroms).
Assignments (5)
ADDRESS CHANGE OF ASSIGNEE
Recorded Jun 5, 2017
From: ZOETIS SERVICES LLC
To: ZOETIS SERVICES LLC
Reel/Frame 042683/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 22, 2013
From: PHARMACIA & UPJOHN COMPANY LLC
To: PAH P&U LLC
Reel/Frame 030066/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 23, 2005
From: SUN, CHANGQUAN; O'CONNOR, GARRY
To: PHARMACIA & UPJOHN COMPANY LLC
Reel/Frame 016048/0400 →